AI Assistant
Blog
Pricing
Log In
Sign Up
Mogamulizumab, an Anti-CCR4 Antibody, Targets Human T-Lymphotropic Virus Type 1–infected CD8
+
and CD4
+
T Cells to Treat Associated Myelopathy
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.